Add deal
← to Company overview

Boehringer Ingelheim Venture Fund

Year founded

-

Country of origin

Germany

HQ country

Germany

Total deal value

Login to see more

Average deal value

Login to see more

Company industry

  • Venture Capital

M&A expertise

  • Venture Capital Management

Industry expertise

  • Venture Capital
Company background

-

Latest deals
AgomAb Therapeutic raises Series B funding 10-03-2021 € 61.50 million eTheRNA raises EUR 34 million in Series B investment round 16-06-2020 € 34 million ImCheck Therapeutics raises EUR 48 million in Series B investment round 04-12-2019 € 48 million Aelin Therapeutics raises EUR 27 million in Series A investment round 11-12-2017 € 27 million Investment round Cardior Pharmaceuticals led by LSP 11-05-2017 € 15 million Show all 7 deals
Contact information

Want to see more?

Interested to see more details? Get your Dealmaker subscription today!

Start optimising your deal analysis Start optimising your deal analysis

Already have an account? Please login

Almost there!

You are only one step away from access to the most comprehensive deal database of the Netherlands and Belgium.

Start optimising your deal analysis Start optimising your deal analysis

Already have an account? Please login